Loss of Raf-1-binding activity of v-Ha-Ras by the deletion of amino acid residues 64-72 and 143-151.

In order to elucidate the molecular events in signal transduction, examination of the interaction between Ras and Raf-1 seems crucial. Many Raf-1 mutants have been investigated in terms of their binding activities to Ras, where only a few Ras mutants have been examined thus far. We have investigated the Raf-1-binding activities of v-Ha-Ras and 21 insertion/deletion mutants of this protein. The results show that the mutants have varying levels of Raf-1-binding activity that are related neither to their transforming activity nor to their guanine nucleotide-binding activity. Deletion in the effector domain of Ras did not completely abolish Raf-1-binding, whereas the deletion in amino acid residues 64-72 or 143-151 resulted in complete loss of Raf-1-binding activity.

[1]  M. Weber,et al.  Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. , 1993, Science.

[2]  D. Lowy,et al.  Mutational analysis of a ras catalytic domain , 1986, Molecular and cellular biology.

[3]  W. Kolch,et al.  Raf-1 protein kinase is required for growth of induced NIH/3T3 cells , 1991, Nature.

[4]  S. Sakiyama,et al.  Cysteine proteinase inhibitors and ras gene products share the same biological activities including transforming activity toward NIH3T3 mouse fibroblasts and the differentiation-inducing activity toward PC12 rat pheochromocytoma cells. , 1990, Carcinogenesis.

[5]  S. Yokoyama,et al.  Degradation of a cAMP-binding protein is inhibited by human c-Ha-ras gene products. , 1987, Biochemical and biophysical research communications.

[6]  S H Kim,et al.  Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. , 1992, Science.

[7]  S. Demo,et al.  ralGDS family members interact with the effector loop of ras p21 , 1994, Molecular and cellular biology.

[8]  W. Xie,et al.  The cysteine-rich region of raf-1 kinase contains zinc, translocates to liposomes, and is adjacent to a segment that binds GTP-ras. , 1994, The Journal of biological chemistry.

[9]  L. Sanz,et al.  Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta. , 1994, The Journal of biological chemistry.

[10]  S. Sakiyama,et al.  v‐Ha‐Ras insertion/deletion mutants with reduced protease‐inhibitory activity have no transforming activity , 1993, FEBS letters.

[11]  A. Wolfman,et al.  Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets. , 1995, Oncogene.

[12]  S. Elledge,et al.  Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1 , 1993, Nature.

[13]  D. Lowy,et al.  Transforming p21 ras protein: flexibility in the major variable region linking the catalytic and membrane‐anchoring domains. , 1985, The EMBO journal.

[14]  G. Landreth,et al.  The mitogen-activated protein kinase cascade is activated by B-Raf in response to nerve growth factor through interaction with p21ras , 1994, Molecular and cellular biology.

[15]  S. Sakiyama,et al.  c‐Ha‐ras gene products are potent inhibitors of cathepsins B and L , 1987, FEBS letters.

[16]  F. McCormick,et al.  A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. , 1987, Science.

[17]  C. Der,et al.  Two Distinct Raf Domains Mediate Interaction with Ras (*) , 1995, The Journal of Biological Chemistry.

[18]  H. Maruta,et al.  The minimal fragments of c-Raf-1 and NF1 that can suppress v-Ha-Ras-induced malignant phenotype. , 1994, The Journal of biological chemistry.

[19]  M. Shirouzu,et al.  Mutations that abolish the ability of Ha-Ras to associate with Raf-1. , 1994, Oncogene.

[20]  X. F. Zhang,et al.  Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues , 1994, Molecular and cellular biology.

[21]  R. Jove,et al.  Raf-1 N-terminal sequences necessary for Ras-Raf interaction and signal transduction , 1995, Molecular and cellular biology.

[22]  P. Warne,et al.  Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro , 1993, Nature.

[23]  T. Bonner,et al.  Structure and biological activity of human homologs of the raf/mil oncogene , 1985, Molecular and cellular biology.

[24]  Michael J. Fry,et al.  Phosphatidylinositol-3-OH kinase direct target of Ras , 1994, Nature.